Literature DB >> 17638023

Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis.

Andreas Fusshoeller1.   

Abstract

In long-term peritoneal dialysis (PD) morphological and functional changes of the peritoneal membrane are common. Sub-mesothelial fibrosis, angiogenesis and vasculopathy are typical histomorphological alterations of the peritoneal membrane, which, to a certain degree, are induced by uremia and recurrent peritonitis. The most important causative factor, however, represents the chronic exposure to PD solutions. Glucose, glucose degradation products and advanced glycation end-products (AGEs) via different pathways induce inflammation, fibrosis and angiogenesis. As a functional consequence ultrafiltration failure due to peritoneal hyperpermeability and an increased effective peritoneal surface area represents a major clinical problem. An insufficient function of the water-selective aquaporin 1 (AQP-1) channel may also be causative for inadequate ultrafiltration. A rare but life-threatening complication of long-term PD is encapsulating peritoneal sclerosis (EPS). For both impaired AQP-1 function and EPS, the long-term effects of PD fluids are believed to be responsible, even though the mechanisms are not yet understood. The avoidance of glucose and modern PD fluids with fewer glucose degradation products, as well as first pharmacological attempts may help to preserve the peritoneal membrane in the long term.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638023     DOI: 10.1007/s00467-007-0541-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  42 in total

1.  The role of vascular endothelial growth factor in peritoneal hyperpermeability during CAPD-related peritonitis.

Authors:  Cheuk-Chun Szeto; Teresa Yuk-Hwa Wong; Ka-Bik Lai; Kai-Ming Chow; Philip Kam-Tao Li
Journal:  Perit Dial Int       Date:  2002 Mar-Apr       Impact factor: 1.756

Review 2.  Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions.

Authors:  Siska Mortier; An S De Vriese; Norbert Lameire
Journal:  Blood Purif       Date:  2003       Impact factor: 2.614

Review 3.  Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures.

Authors:  Yoshindo Kawaguchi; Akira Saito; Hideki Kawanishi; Masaaki Nakayama; Masanobu Miyazaki; Hidetomo Nakamoto; Anders Tranaeus
Journal:  Perit Dial Int       Date:  2005-04       Impact factor: 1.756

Review 4.  Epithelial-to-mesenchymal transition of the mesothelial cell--its role in the response of the peritoneum to dialysis.

Authors:  Rafael Selgas; Auxiliadora Bajo; José A Jiménez-Heffernan; Jose A Sánchez-Tomero; Gloria Del Peso; Abelardo Aguilera; Manuel López-Cabrera
Journal:  Nephrol Dial Transplant       Date:  2006-07       Impact factor: 5.992

5.  Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription.

Authors:  Simon J Davies; Edwina A Brown; Niels E Frandsen; Anabela S Rodrigues; Ana Rodriguez-Carmona; Andreas Vychytil; Evelyne Macnamara; Agneta Ekstrand; Anders Tranaeus; Jose C Divino Filho
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

6.  Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome.

Authors:  Ho Yung Lee; Hoon Young Choi; Hyeong Cheon Park; Bo Jeung Seo; Jun Young Do; Sung Ro Yun; Hyun Yong Song; Yeong Hoon Kim; Yong-Lim Kim; Dae Joong Kim; Yong Soo Kim; Moon Jae Kim; Sug Kyun Shin
Journal:  Nephrol Dial Transplant       Date:  2006-09-06       Impact factor: 5.992

7.  Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study.

Authors:  Watske Smit; Natalie Schouten; Nicole van den Berg; Monique J Langedijk; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2004 Nov-Dec       Impact factor: 1.756

8.  Free-water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD.

Authors:  Watske Smit; Nicole van den Berg; Natalie Schouten; Esther Aikens; Dirk G Struijk; Raymond T Krediet
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

9.  Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis.

Authors:  J W Dobbie; M Zaki; L Wilson
Journal:  Scott Med J       Date:  1981-07       Impact factor: 0.729

10.  Transperitoneal water transport before, during, and after episodes with infectious peritonitis in patients treated with CAPD.

Authors:  Gry E Albrektsen; Tor-Erik Widerøe; Tom I L Nilsen; Pål Romundstad; Maria Radtke; Stein Hallan; Knut Aasarød; Cecilia Øien; Inger K Laegreid
Journal:  Am J Kidney Dis       Date:  2004-03       Impact factor: 8.860

View more
  15 in total

1.  Dialysate CA125 levels after 5 years on continuous peritoneal dialysis.

Authors:  Cengiz Candan; Pınar Turhan; Lale Sever; Mahmut Civilibal; Nur Canpolat; Salim Caliskan; Ozgur Kasapcopur; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2011-01-29       Impact factor: 3.714

2.  Chronic abdominal pain in a patient on chronic peritoneal dialysis: answer.

Authors:  Olivera Marsenic; Bernard Kaplan; Kevin E C Meyers
Journal:  Pediatr Nephrol       Date:  2008-07-09       Impact factor: 3.714

3.  Influence of local inflammation of the peritoneal membrane on diuresis and residual renal function in patients treated with peritoneal dialysis.

Authors:  Ivo Jelicic; Dragan Ljutic; Milenka Sain; Vedran Kovacic; Josipa Radic
Journal:  J Artif Organs       Date:  2011-09-15       Impact factor: 1.731

4.  High glucose promotes TGF-β1 production by inducing FOS expression in human peritoneal mesothelial cells.

Authors:  Keiko Kokoroishi; Ayumu Nakashima; Shigehiro Doi; Toshinori Ueno; Toshiki Doi; Yukio Yokoyama; Kiyomasa Honda; Masami Kanawa; Yukio Kato; Nobuoki Kohno; Takao Masaki
Journal:  Clin Exp Nephrol       Date:  2015-05-28       Impact factor: 2.801

5.  Suramin inhibits the development and progression of peritoneal fibrosis.

Authors:  Chongxiang Xiong; Na Liu; Lu Fang; Shougang Zhuang; Haidong Yan
Journal:  J Pharmacol Exp Ther       Date:  2014-08-28       Impact factor: 4.030

Review 6.  The Role of Tyrosine Kinase Receptors in Peritoneal Fibrosis.

Authors:  Li Wang; Shougang Zhuang
Journal:  Perit Dial Int       Date:  2015 Sep-Oct       Impact factor: 1.756

7.  Bioincompatible impact of different peritoneal dialysis fluid components and therapeutic interventions as tested in a rat peritoneal dialysis model.

Authors:  Andrea W D Stavenuiter; Karima Farhat; Margot N Schilte; Piet M Ter Wee; Robert H J Beelen
Journal:  Int J Nephrol       Date:  2011-08-02

8.  Aliskiren prevents the toxic effects of peritoneal dialysis fluids during chronic dialysis in rats.

Authors:  Juan Pérez-Martínez; Francisco C Pérez-Martínez; Blanca Carrión; Jesús Masiá; Agustín Ortega; Esther Simarro; Syong H Nam-Cha; Valentín Ceña
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study.

Authors:  Bernard G Jaar; Laura C Plantinga; Deidra C Crews; Nancy E Fink; Nasser Hebah; Josef Coresh; Alan S Kliger; Neil R Powe
Journal:  BMC Nephrol       Date:  2009-02-06       Impact factor: 2.388

10.  Associations between dialysate interleukin-6 and Tie-2 and peritoneal solute transport rate and outcomes for patients undergoing peritoneal dialysis: A prospective cohort study.

Authors:  Ying Hang; Hao Yan; He Zhang; Zhenyuan Li; Wei Fang
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.